U.S. Scraps Maryland Vaccine Maker's Multimillion Dollar DealThe federal government has canceled a multimillion dollar deal with Emergent BioSolutions, a Maryland-based vaccine manufacturer with facilities in Baltimore that were found to have produced millions of contaminated Johnson & Johnson vaccine doses this spring, the Washington Post reported.
Johnson & Johnson's Covid-19 Vaccine Is 73.6% Effective, According To New Real-World StudyData from a real-world study assessing Johnson & Johnson's Covid-19 vaccine finds it is 73.6% effective, according to research published Tuesday in the journal JAMA Network Open.
COVID-19 In Maryland: Cases Jump To 731, State Reports More Than 21K New Booster ShotsMaryland reported 731 new COVID-19 cases and 13 new deaths, according to state health department data released Wednesday morning.
Are You Eligible For A COVID-19 Booster? MD Has A New Web Portal To Help You Find OutWith COVID-19 boosters now available statewide, Maryland officials on Monday launched a new web portal to help residents determine if they are one of the nearly 1.4 million people in the state eligible for another shot.
Hogan Authorizes State Health Officials To Administer Moderna, J&J BoostersFollowing the U.S. Centers for Disease Control and Prevention's final approval of Moderna and Johnson & Johnson booster shots, Gov. Larry Hogan on Friday authorized state health officials to administer additional doses from those makers to eligible Marylanders.
FDA OKs Mixing COVID Vaccines; Backs Moderna, J&J BoostersU.S. regulators on Wednesday signed off on extending COVID-19 boosters to Americans who got the Moderna or Johnson & Johnson vaccine and said anyone eligible for an extra dose can get a brand different from the one they received initially.
Booster Shots Could Soon Be Recommended For People As Young As 40, Source SaysBooster protection could soon expand to a much broader population, as a source says the US government likely will soon recommend additional doses to people as young as 40 who received a Moderna or Pfizer Covid-19 vaccine.
FDA Committee Recommends Boosters For Johnson & Johnson, Final Authorization Could Come Next WeekA month after an FDA panel approved a booster for the Pfizer vaccine, that panel late this week unanimously recommended the same for other vaccines--Thursday for Moderna and Friday the Johnson & Johnson single-shot.
FDA Advisory Panel Endorses Booster Doses Of Johnson & Johnson's Single-Shot COVID-19 VaccineA panel of U.S. health advisers endorsed booster doses of Johnson & Johnson’s single-shot COVID-19 vaccine Friday, saying they should be offered at least two months after immunization.
Who's Eligible? Maryland Authorizes Pfizer Booster Shots For Vulnerable Adults In Coronavirus FightMaryland immediately authorized Pfizer booster shots following the CDC director’s stamp of approval. Those eligible include everyone age 65 and older who has been fully vaccinated for six months, adults with certain underlying health conditions, adults living in congregate living, and those at risk because of their job.
Now That Students Have Returned To The Classroom, One Question Remains: Are Children Safe?Students are back in school and scientists along with doctors are trying to get a handle on how the pandemic is being tracked as large numbers of kids are congregated in school buildings.